Evaxion A (EVAX) Net Income - Minority (2022 - 2023)
Evaxion A (EVAX) reported Net Income - Minority of -$2.5 million for Q2 2023, up 87.42% on a YoY basis from -$1.4 million in Q2 2022, and up 61.44% quarter-over-quarter from -$6.6 million in Q1 2023.
Evaxion A (EVAX) Net Income - Minority (2022 - 2023) Analysis & Trends
Evaxion A has reported Net Income - Minority for 2 years, with the latest figure at -$2.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2.54 Mn |
| Mar 31, 2023 | -6.58 Mn |
| Jun 30, 2022 | -20.15 Mn |